Home >> Medical Devices >> Food & Beverage >>

Global Nuclear Medicine Market Status & Trend Report 2018-2023 Top 20 Countries Data

Published: Oct-2018 | Format: PDF | MIReports | Number of pages: 156 | Code: MRS - 325953

Report Summary

Nuclear Medicine Market Status & Trend Report 2018-2023 Top 20 Countries Data offers a comprehensive analysis on Nuclear Medicine industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Global and Top 20 Countries Market Size of Nuclear Medicine 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Nuclear Medicine worldwide and market share by regions, with company and product introduction, position in the Nuclear Medicine market
Market status and development trend of Nuclear Medicine by types and applications
Cost and profit status of Nuclear Medicine, and marketing status
Market growth drivers and challenges

The report segments the global Nuclear Medicine market as:

Global Nuclear Medicine Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2018-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa

Global Nuclear Medicine Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2018-2023):
SPECT Radiopharmaceuticals
PET Radiopharmaceuticals

Global Nuclear Medicine Market: Application Segment Analysis (Consumption Volume and Market Share 2018-2023; Downstream Customers and Market Analysis)
SPECT
PET

Global Nuclear Medicine Market: Manufacturers Segment Analysis (Company and Product introduction, Nuclear Medicine Sales Volume, Revenue, Price and Gross Margin):
GE Healthcare
Philips Healthcare
Siemens Healthcare
Toshiba
Hitachi
Carestream
Esaote
Shimadzu
TriFoil Imaging
Biosensors International Group, Ltd

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table of Contents
Chapter 1 Overview of Nuclear Medicine
    1.1 Definition of Nuclear Medicine in This Report
    1.2 Commercial Types of Nuclear Medicine
        1.2.1 SPECT Radiopharmaceuticals
        1.2.2 PET Radiopharmaceuticals
    1.3 Downstream Application of Nuclear Medicine
        1.3.1 SPECT
        1.3.2 PET
    1.4 Development History of Nuclear Medicine
    1.5 Market Status and Trend of Nuclear Medicine 2013-2023
        1.5.1 Global Nuclear Medicine Market Status and Trend 2013-2023
        1.5.2 Regional Nuclear Medicine Market Status and Trend 2013-2023
Chapter 2 Global Market Status and Forecast by Regions
    2.1 Market Development of Nuclear Medicine 2013-2017
    2.2 Sales Market of Nuclear Medicine by Regions
        2.2.1 Sales Volume of Nuclear Medicine by Regions
        2.2.2 Sales Value of Nuclear Medicine by Regions
    2.3 Production Market of Nuclear Medicine by Regions
    2.4 Global Market Forecast of Nuclear Medicine 2018-2023
        2.4.1 Global Market Forecast of Nuclear Medicine 2018-2023
        2.4.2 Market Forecast of Nuclear Medicine by Regions 2018-2023
Chapter 3 Global Market Status and Forecast by Types
    3.1 Sales Volume of Nuclear Medicine by Types
    3.2 Sales Value of Nuclear Medicine by Types
    3.3 Market Forecast of Nuclear Medicine by Types
Chapter 4 Global Market Status and Forecast by Downstream Industry
    4.1 Global Sales Volume of Nuclear Medicine by Downstream Industry
    4.2 Global Market Forecast of Nuclear Medicine by Downstream Industry
Chapter 5 North America Market Status by Countries, Type, Manufacturers and Downstream Industry
    5.1 North America Nuclear Medicine Market Status by Countries
        5.1.1 North America Nuclear Medicine Sales by Countries (2013-2017)
        5.1.2 North America Nuclear Medicine Revenue by Countries (2013-2017)
        5.1.3 United States Nuclear Medicine Market Status (2013-2017)
        5.1.4 Canada Nuclear Medicine Market Status (2013-2017)
        5.1.5 Mexico Nuclear Medicine Market Status (2013-2017)
    5.2 North America Nuclear Medicine Market Status by Manufacturers
    5.3 North America Nuclear Medicine Market Status by Type (2013-2017)
        5.3.1 North America Nuclear Medicine Sales by Type (2013-2017)
        5.3.2 North America Nuclear Medicine Revenue by Type (2013-2017)
    5.4 North America Nuclear Medicine Market Status by Downstream Industry (2013-2017)
Chapter 6 Europe Market Status by Countries, Type, Manufacturers and Downstream Industry
    6.1 Europe Nuclear Medicine Market Status by Countries
        6.1.1 Europe Nuclear Medicine Sales by Countries (2013-2017)
        6.1.2 Europe Nuclear Medicine Revenue by Countries (2013-2017)
        6.1.3 Germany Nuclear Medicine Market Status (2013-2017)
        6.1.4 UK Nuclear Medicine Market Status (2013-2017)
        6.1.5 France Nuclear Medicine Market Status (2013-2017)
        6.1.6 Italy Nuclear Medicine Market Status (2013-2017)
        6.1.7 Russia Nuclear Medicine Market Status (2013-2017)
        6.1.8 Spain Nuclear Medicine Market Status (2013-2017)
        6.1.9 Benelux Nuclear Medicine Market Status (2013-2017)
    6.2 Europe Nuclear Medicine Market Status by Manufacturers
    6.3 Europe Nuclear Medicine Market Status by Type (2013-2017)
        6.3.1 Europe Nuclear Medicine Sales by Type (2013-2017)
        6.3.2 Europe Nuclear Medicine Revenue by Type (2013-2017)
    6.4 Europe Nuclear Medicine Market Status by Downstream Industry (2013-2017)
Chapter 7 Asia Pacific Market Status by Countries, Type, Manufacturers and Downstream Industry
    7.1 Asia Pacific Nuclear Medicine Market Status by Countries
        7.1.1 Asia Pacific Nuclear Medicine Sales by Countries (2013-2017)
        7.1.2 Asia Pacific Nuclear Medicine Revenue by Countries (2013-2017)
        7.1.3 China Nuclear Medicine Market Status (2013-2017)
        7.1.4 Japan Nuclear Medicine Market Status (2013-2017)
        7.1.5 India Nuclear Medicine Market Status (2013-2017)
        7.1.6 Southeast Asia Nuclear Medicine Market Status (2013-2017)
        7.1.7 Australia Nuclear Medicine Market Status (2013-2017)
    7.2 Asia Pacific Nuclear Medicine Market Status by Manufacturers
    7.3 Asia Pacific Nuclear Medicine Market Status by Type (2013-2017)
        7.3.1 Asia Pacific Nuclear Medicine Sales by Type (2013-2017)
        7.3.2 Asia Pacific Nuclear Medicine Revenue by Type (2013-2017)
    7.4 Asia Pacific Nuclear Medicine Market Status by Downstream Industry (2013-2017)
Chapter 8 Latin America Market Status by Countries, Type, Manufacturers and Downstream Industry
    8.1 Latin America Nuclear Medicine Market Status by Countries
        8.1.1 Latin America Nuclear Medicine Sales by Countries (2013-2017)
        8.1.2 Latin America Nuclear Medicine Revenue by Countries (2013-2017)
        8.1.3 Brazil Nuclear Medicine Market Status (2013-2017)
        8.1.4 Argentina Nuclear Medicine Market Status (2013-2017)
        8.1.5 Colombia Nuclear Medicine Market Status (2013-2017)
    8.2 Latin America Nuclear Medicine Market Status by Manufacturers
    8.3 Latin America Nuclear Medicine Market Status by Type (2013-2017)
        8.3.1 Latin America Nuclear Medicine Sales by Type (2013-2017)
        8.3.2 Latin America Nuclear Medicine Revenue by Type (2013-2017)
    8.4 Latin America Nuclear Medicine Market Status by Downstream Industry (2013-2017)
Chapter 9 Middle East and Africa Market Status by Countries, Type, Manufacturers and Downstream Industry
    9.1 Middle East and Africa Nuclear Medicine Market Status by Countries
        9.1.1 Middle East and Africa Nuclear Medicine Sales by Countries (2013-2017)
        9.1.2 Middle East and Africa Nuclear Medicine Revenue by Countries (2013-2017)
        9.1.3 Middle East Nuclear Medicine Market Status (2013-2017)
        9.1.4 Africa Nuclear Medicine Market Status (2013-2017)
    9.2 Middle East and Africa Nuclear Medicine Market Status by Manufacturers
    9.3 Middle East and Africa Nuclear Medicine Market Status by Type (2013-2017)
        9.3.1 Middle East and Africa Nuclear Medicine Sales by Type (2013-2017)
        9.3.2 Middle East and Africa Nuclear Medicine Revenue by Type (2013-2017)
    9.4 Middle East and Africa Nuclear Medicine Market Status by Downstream Industry (2013-2017)
Chapter 10 Market Driving Factor Analysis of Nuclear Medicine
    10.1 Global Economy Situation and Trend Overview
    10.2 Nuclear Medicine Downstream Industry Situation and Trend Overview
Chapter 11 Nuclear Medicine Market Competition Status by Major Manufacturers
    11.1 Production Volume of Nuclear Medicine by Major Manufacturers
    11.2 Production Value of Nuclear Medicine by Major Manufacturers
    11.3 Basic Information of Nuclear Medicine by Major Manufacturers
        11.3.1 Headquarters Location and Established Time of Nuclear Medicine Major Manufacturer
        11.3.2 Employees and Revenue Level of Nuclear Medicine Major Manufacturer
    11.4 Market Competition News and Trend
        11.4.1 Merger, Consolidation or Acquisition News
        11.4.2 Investment or Disinvestment News
        11.4.3 New Product Development and Launch
Chapter 12 Nuclear Medicine Major Manufacturers Introduction and Market Data
    12.1 GE Healthcare
        12.1.1 Company profile
        12.1.2 Representative Nuclear Medicine Product
        12.1.3 Nuclear Medicine Sales, Revenue, Price and Gross Margin of GE Healthcare
    12.2 Philips Healthcare
        12.2.1 Company profile
        12.2.2 Representative Nuclear Medicine Product
        12.2.3 Nuclear Medicine Sales, Revenue, Price and Gross Margin of Philips Healthcare
    12.3 Siemens Healthcare
        12.3.1 Company profile
        12.3.2 Representative Nuclear Medicine Product
        12.3.3 Nuclear Medicine Sales, Revenue, Price and Gross Margin of Siemens Healthcare
    12.4 Toshiba
        12.4.1 Company profile
        12.4.2 Representative Nuclear Medicine Product
        12.4.3 Nuclear Medicine Sales, Revenue, Price and Gross Margin of Toshiba
    12.5 Hitachi
        12.5.1 Company profile
        12.5.2 Representative Nuclear Medicine Product
        12.5.3 Nuclear Medicine Sales, Revenue, Price and Gross Margin of Hitachi
    12.6 Carestream
        12.6.1 Company profile
        12.6.2 Representative Nuclear Medicine Product
        12.6.3 Nuclear Medicine Sales, Revenue, Price and Gross Margin of Carestream
    12.7 Esaote
        12.7.1 Company profile
        12.7.2 Representative Nuclear Medicine Product
        12.7.3 Nuclear Medicine Sales, Revenue, Price and Gross Margin of Esaote
    12.8 Shimadzu
        12.8.1 Company profile
        12.8.2 Representative Nuclear Medicine Product
        12.8.3 Nuclear Medicine Sales, Revenue, Price and Gross Margin of Shimadzu
    12.9 TriFoil Imaging
        12.9.1 Company profile
        12.9.2 Representative Nuclear Medicine Product
        12.9.3 Nuclear Medicine Sales, Revenue, Price and Gross Margin of TriFoil Imaging
    12.10 Biosensors International Group, Ltd
        12.10.1 Company profile
        12.10.2 Representative Nuclear Medicine Product
        12.10.3 Nuclear Medicine Sales, Revenue, Price and Gross Margin of Biosensors International Group, Ltd
Chapter 13 Upstream and Downstream Market Analysis of Nuclear Medicine
    13.1 Industry Chain of Nuclear Medicine
    13.2 Upstream Market and Representative Companies Analysis
    13.3 Downstream Market and Representative Companies Analysis
Chapter 14 Cost and Gross Margin Analysis of Nuclear Medicine
    14.1 Cost Structure Analysis of Nuclear Medicine
    14.2 Raw Materials Cost Analysis of Nuclear Medicine
    14.3 Labor Cost Analysis of Nuclear Medicine
    14.4 Manufacturing Expenses Analysis of Nuclear Medicine
Chapter 15 Report Conclusion
Chapter 16 Research Methodology and Reference
    16.1 Methodology/Research Approach
        16.1.1 Research Programs/Design
        16.1.2 Market Size Estimation
        16.1.3 Market Breakdown and Data Triangulation
    16.2 Data Source
        16.2.1 Secondary Sources
        16.2.2 Primary Sources
    16.3 Reference


List of Tables

    Table Advantage and Disadvantage of SPECT Radiopharmaceuticals
    Table Advantage and Disadvantage of PET Radiopharmaceuticals
    Table Sales Volume of Nuclear Medicine by Regions 2013-2017
    Table Sales Value of Nuclear Medicine by Regions 2013-2017
    Table Production Volume of Nuclear Medicine by Regions 2013-2017
    Table Global Sales Volume of Nuclear Medicine by Regions 2018-2023
    Table Global Sales Value of Nuclear Medicine by Regions 2018-2023
    Table Global Production Volume of Nuclear Medicine by Regions 2018-2023
    Table Sales Volume of Nuclear Medicine by Types 2013-2017
    Table Sales Value of Nuclear Medicine by Types 2013-2017
    Table Sales Volume Forecast of Nuclear Medicine by Types 2018-2023
    Table Sales Value Forecast of Nuclear Medicine by Types 2018-2023
    Table Sales Volume of Nuclear Medicine by Downstream Industry 2013-2017
    Table Sales Volume Forecast of Nuclear Medicine by Downstream Industry 2018-2023
    Table North America Nuclear Medicine Sales by Countries (2013-2017)
    Table North America Nuclear Medicine Sales Share by Countries (2013-2017)
    Table North America Nuclear Medicine Revenue by Countries (2013-2017)
    Table North America Nuclear Medicine Revenue Market Share by Countries (2013-2017)
    Table North America Nuclear Medicine Sales by Type (2013-2017)
    Table North America Nuclear Medicine Sales Share by Type (2013-2017)
    Table North America Nuclear Medicine Revenue by Type (2013-2017)
    Table North America Nuclear Medicine Revenue Share by Type (2013-2017)
    Table North America Nuclear Medicine Sales by Downstream Industry (2013-2017)
    Table North America Nuclear Medicine Sales Share by Downstream Industry (2013-2017)
    Table Europe Nuclear Medicine Sales by Countries (2013-2017)
    Table Europe Nuclear Medicine Sales Share by Countries (2013-2017)
    Table Europe Nuclear Medicine Revenue by Countries (2013-2017)
    Table Europe Nuclear Medicine Revenue Market Share by Countries (2013-2017)
    Table Europe Nuclear Medicine Sales by Type (2013-2017)
    Table Europe Nuclear Medicine Sales Share by Type (2013-2017)
    Table Europe Nuclear Medicine Revenue by Type (2013-2017)
    Table Europe Nuclear Medicine Revenue Share by Type (2013-2017)
    Table Europe Nuclear Medicine Sales by Downstream Industry (2013-2017)
    Table Europe Nuclear Medicine Sales Share by Downstream Industry (2013-2017)
    Table Asia Pacific Nuclear Medicine Sales by Countries (2013-2017)
    Table Asia Pacific Nuclear Medicine Sales Share by Countries (2013-2017)
    Table Asia Pacific Nuclear Medicine Revenue by Countries (2013-2017)
    Table Asia Pacific Nuclear Medicine Revenue Market Share by Countries (2013-2017)
    Table Asia Pacific Nuclear Medicine Sales by Type (2013-2017)
    Table Asia Pacific Nuclear Medicine Sales Share by Type (2013-2017)
    Table Asia Pacific Nuclear Medicine Revenue by Type (2013-2017)
    Table Asia Pacific Nuclear Medicine Revenue Share by Type (2013-2017)
    Table Asia Pacific Nuclear Medicine Sales by Downstream Industry (2013-2017)
    Table Asia Pacific Nuclear Medicine Sales Share by Downstream Industry (2013-2017)
    Table Latin America Nuclear Medicine Sales by Countries (2013-2017)
    Table Latin America Nuclear Medicine Sales Share by Countries (2013-2017)
    Table Latin America Nuclear Medicine Revenue by Countries (2013-2017)
    Table Latin America Nuclear Medicine Revenue Market Share by Countries (2013-2017)
    Table Latin America Nuclear Medicine Sales by Type (2013-2017)
    Table Latin America Nuclear Medicine Sales Share by Type (2013-2017)
    Table Latin America Nuclear Medicine Revenue by Type (2013-2017)
    Table Latin America Nuclear Medicine Revenue Share by Type (2013-2017)
    Table Latin America Nuclear Medicine Sales by Downstream Industry (2013-2017)
    Table Latin America Nuclear Medicine Sales Share by Downstream Industry (2013-2017)
    Table Middle East and Africa Nuclear Medicine Sales by Regions (2013-2017)
    Table Middle East and Africa Nuclear Medicine Sales Share by Regions (2013-2017)
    Table Middle East and Africa Nuclear Medicine Revenue by Regions (2013-2017)
    Table Middle East and Africa Nuclear Medicine Revenue Market Share by Regions (2013-2017)
    Table Middle East and Africa Nuclear Medicine Sales by Type (2013-2017)
    Table Middle East and Africa Nuclear Medicine Sales Share by Type (2013-2017)
    Table Middle East and Africa Nuclear Medicine Revenue by Type (2013-2017)
    Table Middle East and Africa Nuclear Medicine Revenue Share by Type (2013-2017)
    Table Middle East and Africa Nuclear Medicine Sales by Downstream Industry (2013-2017)
    Table Middle East and Africa Nuclear Medicine Sales Share by Downstream Industry (2013-2017)
    Table Production Volume of Nuclear Medicine by Major Manufacturers 2013-2017
    Table Production Value of Nuclear Medicine by Major Manufacturers 2013-2017
    Table Headquarters Location and Established Time of Nuclear Medicine Major Manufacturer
    Table Employees and Revenue Level of Nuclear Medicine Major Manufacturer
    Table Representative Nuclear Medicine Product One of GE Healthcare
    Table Representative Nuclear Medicine Product Two of GE Healthcare
    Table Nuclear Medicine Sales, Revenue, Price and Gross Margin of GE Healthcare 2013-2017
    Table Representative Nuclear Medicine Product One of Philips Healthcare
    Table Representative Nuclear Medicine Product Two of Philips Healthcare
    Table Nuclear Medicine Sales, Revenue, Price and Gross Margin of Philips Healthcare 2013-2017
    Table Representative Nuclear Medicine Product One of Siemens Healthcare
    Table Representative Nuclear Medicine Product Two of Siemens Healthcare
    Table Nuclear Medicine Sales, Revenue, Price and Gross Margin of Siemens Healthcare 2013-2017
    Table Representative Nuclear Medicine Product One of Toshiba
    Table Representative Nuclear Medicine Product Two of Toshiba
    Table Nuclear Medicine Sales, Revenue, Price and Gross Margin of Toshiba 2013-2017
    Table Representative Nuclear Medicine Product One of Hitachi
    Table Representative Nuclear Medicine Product Two of Hitachi
    Table Nuclear Medicine Sales, Revenue, Price and Gross Margin of Hitachi 2013-2017
    Table Representative Nuclear Medicine Product One of Carestream
    Table Representative Nuclear Medicine Product Two of Carestream
    Table Nuclear Medicine Sales, Revenue, Price and Gross Margin of Carestream 2013-2017
    Table Representative Nuclear Medicine Product One of Esaote
    Table Representative Nuclear Medicine Product Two of Esaote
    Table Nuclear Medicine Sales, Revenue, Price and Gross Margin of Esaote 2013-2017
    Table Representative Nuclear Medicine Product One of Shimadzu
    Table Representative Nuclear Medicine Product Two of Shimadzu
    Table Nuclear Medicine Sales, Revenue, Price and Gross Margin of Shimadzu 2013-2017
    Table Representative Nuclear Medicine Product One of TriFoil Imaging
    Table Representative Nuclear Medicine Product Two of TriFoil Imaging
    Table Nuclear Medicine Sales, Revenue, Price and Gross Margin of TriFoil Imaging 2013-2017
    Table Representative Nuclear Medicine Product One of Biosensors International Group, Ltd
    Table Representative Nuclear Medicine Product Two of Biosensors International Group, Ltd
    Table Nuclear Medicine Sales, Revenue, Price and Gross Margin of Biosensors International Group, Ltd 2013-2017


List of Figures

    Figure Representative Commercial Product Picture of Nuclear Medicine
    Figure Global Shipments Volume Share of Nuclear Medicine by Types in 2017
    Figure Representative Commercial Product Picture of SPECT Radiopharmaceuticals
    Figure Representative Commercial Product Picture of PET Radiopharmaceuticals
    Figure Demand Volume Share of Nuclear Medicine by Downstream Industry in 2017
    Figure SPECT Examples of Nuclear Medicine
    Figure PET  Examples of Nuclear Medicine
    Figure Global Nuclear Medicine Revenue and Growth Rate 2013-2023
    Figure Global Nuclear Medicine Market Size Comparison in 2013, 2017 and 2023
    Figure North America Nuclear Medicine Revenue and Growth Rate 2013-2023
    Figure Europe Nuclear Medicine Revenue and Growth Rate 2013-2023
    Figure Asia Pacific Nuclear Medicine Revenue and Growth Rate 2013-2023
    Figure Latin America Nuclear Medicine Revenue and Growth Rate 2013-2023
    Figure Middle East and Africa Nuclear Medicine Revenue and Growth Rate 2013-2023
    Figure Latin America Nuclear Medicine Revenue and Growth Rate 2013-2023
    Figure Global Sales Volume and Growth Rate of Nuclear Medicine 2013-2017
    Figure Global Sales Value and Growth Rate of Nuclear Medicine 2013-2017
    Figure Sales Volume Share of Nuclear Medicine by Regions 2013-2017
    Figure Sales Volume Share of Nuclear Medicine by Regions in 2013
    Figure Sales Volume Share of Nuclear Medicine by Regions in 2017
    Figure Sales Volume Growth Rate Comparison of Nuclear Medicine by Regions 2013-2017
    Figure Sales Value Share of Nuclear Medicine by Regions 2013-2017
    Figure Sales Value Share of Nuclear Medicine by Regions in 2013
    Figure Sales Value Share of Nuclear Medicine by Regions in 2017
    Figure Sales Value Growth Rate Comparison of Nuclear Medicine by Regions 2013-2017
    Figure Production Volume Share of Nuclear Medicine by Regions 2013-2017
    Figure Production Volume Share of Nuclear Medicine by Regions in 2013
    Figure Production Volume Share of Nuclear Medicine by Regions in 2017
    Figure Global Sales Volume and Growth Rate of Nuclear Medicine 2018-2023
    Figure Global Revenue and Growth Rate of Nuclear Medicine 2018-2023
    Figure Global Sales Volume Share of Nuclear Medicine by Regions in 2023
    Figure Global Sales Value Share of Nuclear Medicine by Regions in 2023
    Figure Global Production Volume Share of Nuclear Medicine by Regions in 2023
    Figure Sales Volume Share of Nuclear Medicine by Types 2013-2017
    Figure Sales Volume Share of Nuclear Medicine by Types in 2013
    Figure Sales Volume Share of Nuclear Medicine by Types in 2017
    Figure Sales Volume Growth Rate Comparison of Nuclear Medicine by Types 2013-2017
    Figure Sales Value Share of Nuclear Medicine by Types 2013-2017
    Figure Sales Value Share of Nuclear Medicine by Types in 2013
    Figure Sales Value Share of Nuclear Medicine by Types in 2017
    Figure Sales Value Growth Rate Comparison of Nuclear Medicine by Types 2013-2017
    Figure Sales Volume Share Forecast of Nuclear Medicine by Types in 2023
    Figure Sales Value Share Forecast of Nuclear Medicine by Types in 2023
    Figure Sales Volume Share of Nuclear Medicine by Downstream Industry 2013-2017
    Figure Sales Volume Share of Nuclear Medicine by Downstream Industry in 2013
    Figure Sales Volume Share of Nuclear Medicine by Downstream Industry in 2017
    Figure Sales Volume Growth Rate Comparison of Nuclear Medicine by Downstream Industry 2013-2017
    Figure Sales Volume Share Forecast of Nuclear Medicine by Downstream Industry in 2023
    Figure North America Nuclear Medicine Sales Share by Countries in 2013
    Figure North America Nuclear Medicine Sales Share by Countries in 2017
    Figure North America Nuclear Medicine Revenue Market Share by Countries in 2013
    Figure North America Nuclear Medicine Revenue Market Share by Countries in 2017
    Figure United States Nuclear Medicine Sales and Growth Rate (2013-2017)
    Figure United States Nuclear Medicine Revenue and Growth Rate (2013-2017)
    Figure Canada Nuclear Medicine Sales and Growth Rate (2013-2017)
    Figure Canada Nuclear Medicine Revenue and Growth Rate (2013-2017)
    Figure Mexico Nuclear Medicine Sales and Growth Rate (2013-2017)
    Figure Mexico Nuclear Medicine Revenue and Growth Rate (2013-2017)
    Figure North America Nuclear Medicine Sales Market Share by Manufacturer in 2017
    Figure Europe Nuclear Medicine Sales Share by Countries in 2013
    Figure Europe Nuclear Medicine Sales Share by Countries in 2017
    Figure Europe Nuclear Medicine Revenue Market Share by Countries in 2013
    Figure Europe Nuclear Medicine Revenue Market Share by Countries in 2017
    Figure Germany Nuclear Medicine Sales and Growth Rate (2013-2017)
    Figure Germany Nuclear Medicine Revenue and Growth Rate (2013-2017)
    Figure UK Nuclear Medicine Sales and Growth Rate (2013-2017)
    Figure UK Nuclear Medicine Revenue and Growth Rate (2013-2017)
    Figure France Nuclear Medicine Sales and Growth Rate (2013-2017)
    Figure France Nuclear Medicine Revenue and Growth Rate (2013-2017)
    Figure Italy Nuclear Medicine Sales and Growth Rate (2013-2017)
    Figure Italy Nuclear Medicine Revenue and Growth Rate (2013-2017)
    Figure Russia Nuclear Medicine Sales and Growth Rate (2013-2017)
    Figure Russia Nuclear Medicine Revenue and Growth Rate (2013-2017)
    Figure Spain Nuclear Medicine Sales and Growth Rate (2013-2017)
    Figure Spain Nuclear Medicine Revenue and Growth Rate (2013-2017)
    Figure Benelux Nuclear Medicine Sales and Growth Rate (2013-2017)
    Figure Benelux Nuclear Medicine Revenue and Growth Rate (2013-2017)
    Figure Europe Nuclear Medicine Sales Market Share by Manufacturer in 2017
    Figure Asia Pacific Nuclear Medicine Sales Share by Countries in 2013
    Figure Asia Pacific Nuclear Medicine Sales Share by Countries in 2017
    Figure Asia Pacific Nuclear Medicine Revenue Market Share by Countries in 2013
    Figure Asia Pacific Nuclear Medicine Revenue Market Share by Countries in 2017
    Figure China Nuclear Medicine Sales and Growth Rate (2013-2017)
    Figure China Nuclear Medicine Revenue and Growth Rate (2013-2017)
    Figure Japan Nuclear Medicine Sales and Growth Rate (2013-2017)
    Figure Japan Nuclear Medicine Revenue and Growth Rate (2013-2017)
    Figure India Nuclear Medicine Sales and Growth Rate (2013-2017)
    Figure India Nuclear Medicine Revenue and Growth Rate (2013-2017)
    Figure Southeast Asia Nuclear Medicine Sales and Growth Rate (2013-2017)
    Figure Southeast Asia Nuclear Medicine Revenue and Growth Rate (2013-2017)
    Figure Australia Nuclear Medicine Sales and Growth Rate (2013-2017)
    Figure Australia Nuclear Medicine Revenue and Growth Rate (2013-2017)
    Figure Asia Pacific Nuclear Medicine Sales Market Share by Manufacturer in 2017
    Figure Latin America Nuclear Medicine Sales Share by Countries in 2013
    Figure Latin America Nuclear Medicine Sales Share by Countries in 2017
    Figure Latin America Nuclear Medicine Revenue Market Share by Countries in 2013
    Figure Latin America Nuclear Medicine Revenue Market Share by Countries in 2017
    Figure Brazil Nuclear Medicine Sales and Growth Rate (2013-2017)
    Figure Brazil Nuclear Medicine Revenue and Growth Rate (2013-2017)
    Figure Argentina Nuclear Medicine Sales and Growth Rate (2013-2017)
    Figure Argentina Nuclear Medicine Revenue and Growth Rate (2013-2017)
    Figure Colombia Nuclear Medicine Sales and Growth Rate (2013-2017)
    Figure Colombia Nuclear Medicine Revenue and Growth Rate (2013-2017)
    Figure Latin America Nuclear Medicine Sales Market Share by Manufacturer in 2017
    Figure Middle East and Africa Nuclear Medicine Sales Share by Regions in 2013
    Figure Middle East and Africa Nuclear Medicine Sales Share by Regions in 2017
    Figure Middle East and Africa Nuclear Medicine Revenue Market Share by Regions in 2013
    Figure Middle East and Africa Nuclear Medicine Revenue Market Share by Regions in 2017
    Figure Middle East Nuclear Medicine Sales and Growth Rate (2013-2017)
    Figure Middle East Nuclear Medicine Revenue and Growth Rate (2013-2017)
    Figure Africa Nuclear Medicine Sales and Growth Rate (2013-2017)
    Figure Africa Nuclear Medicine Revenue and Growth Rate (2013-2017)
    Figure Middle East and Africa Nuclear Medicine Sales Market Share by Manufacturer in 2017
    Figure Production Volume Share of Nuclear Medicine by Major Manufacturers in 2013
    Figure Production Volume Share of Nuclear Medicine by Major Manufacturers in 2017
    Figure Production Value Share of Nuclear Medicine by Major Manufacturers in 2013
    Figure Production Value Share of Nuclear Medicine by Major Manufacturers in 2017
    Figure Nuclear Medicine Revenue and Market Share of GE Healthcare 2013-2017
    Figure Nuclear Medicine Revenue and Market Share of Philips Healthcare 2013-2017
    Figure Nuclear Medicine Revenue and Market Share of Siemens Healthcare 2013-2017
    Figure Nuclear Medicine Revenue and Market Share of Toshiba 2013-2017
    Figure Nuclear Medicine Revenue and Market Share of Hitachi 2013-2017
    Figure Nuclear Medicine Revenue and Market Share of Carestream 2013-2017
    Figure Nuclear Medicine Revenue and Market Share of Esaote 2013-2017
    Figure Nuclear Medicine Revenue and Market Share of Shimadzu 2013-2017

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode
Single User | $(USD)3680 View Pricing